ESG

With record SUBLOCADE revenue and a new U.S. home, Indivior launches a $400M buyback, signaling a new era in its fight against the opioid crisis.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Kolibri Global Energy Inc. just released its first sustainability report. Is it a genuine shift or a strategic play in a world demanding greener energy?

A new collaboration is betting on tiny natural particles to deliver a gene-editing cure for a devastating neurological disorder, bypassing a key medical hurdle.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

Techem's new sustainability report reveals an 11.2% CO2e drop, a major digital rollout with 85% smart devices, and new e-mobility and circular economy goals.

A novel mouse model with human immune receptors promises to slash the high failure rate of antibody therapies, accelerating life-saving treatments.

Fourth iQ 3.0 launches with above-store AI, promising executives a new way to fight rising costs, boost profits, and manage sprawling restaurant empires.

ASUS unveils new liquid-cooling solutions and a partner ecosystem to combat the intense heat of next-gen AI, promising a more sustainable, powerful future.

Vista Gold Corp. launches a major public offering to advance its massive Mt. Todd gold project in Australia, testing investor appetite for junior miners.

After a year focused on organic growth, the environmental firm posted record results and now plans a disciplined return to acquisitions in 2026.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

A new documentary focusing on resilience after 9/11 is gaining global acclaim, merging powerful filmmaking with a mission to educate future generations.

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.

Eton Pharmaceuticals wins landmark FDA approval for DESMODA, a breakthrough liquid drug set to transform care for a rare condition by enabling precise, safe dosing.

Silfab Solar appoints financial veteran Phung Ngo-Burns as CFO, a strategic move to navigate its major U.S. expansion amid a booming domestic solar market.